Vantage Oncology’s network centers reportedly provide an advanced spectrum of radiation therapy, including linear accelerator-based radiosurgery, image-guided radiation therapy (IGRT), intensity-modulated radiation therapy (IMRT), brachytherapy, high dose rate implants (HDR) and 3-D treatment planning, along with appropriate diagnostic tools such as the CT Simulator.

The technology also reportedly supports the recruitment of high-quality physicians, maintains established credibility with referral sources and provides superior marketing leverage against local competition.

Velos Inc.’s eResearch Version 7, a clinical research device aimed to benefit customers, further delivers the power of Web 2.0 technology and system design.

With Version 7, some physicians can reportedly move from test environment to production use in as little as one week. More than 60 functional and system enhancements were incorporated in its release.

May 21, 2007 — Data presented at the International Conference of the American Thoracic Society (ATS) demonstrate that Perforomist (formoterol fumarate) Inhalation Solution, delivered by nebulization, is an effective and well-tolerated new treatment option for patients suffering from emphysema or chronic bronchitis, otherwise known as Chronic Obstructive Pulmonary Disease (COPD).

May 21, 2007 — Welch Allyn and Masimo Corp. have partnered to incorporate Masimo SET pulse oximetry into new versions of the Welch Allyn Spot Vital Signs and Welch Allyn Propaq LT devices.

The two devices allow clinicians to effectively spot check and monitor patients respectively in ambulatory and acute care settings, and can be easily configured for efficient, safe and accurate operation by caregivers with varying levels of training and sophistication.

May 21, 2007 - Patient Comfort Systems Inc. recently announced its new product line of medical imaging table pads and positioners featuring infection-resistant design with permanent antimicrobial agents, created in part to address the growing threat of infections spread by contact, which includes aggressive antibiotic-resistant bacteria, or “super bugs,” such as MRSA (Methicillin-Resistant Staphylococcus Aureus).

May 21, 2007 — A new study released by the American Thoracic Society found that medical residents working within the mandated maximum of 80 hours per week experience severe sleepiness, a finding that may have implications for both patient care and resident safety.

May 21, 2007 — Reuters news service reports that a group of Chinese of scientists has developed a glucose meter that allows patients to check their sugar levels without using a finger stick.

The device, which is not named, checks glucose levels by using a weak form of infrared to penetrate the skin on the finger and monitor the blood stream. After undergoing five clinical trials, the device is said to give results with 85 percent accuracy, according to Reuters.

May 21, 2007 — Newswise reports that Vanderbilt study of intensive care unit patients who are breathing with the help of a mechanical ventilator found that a two-step sedation and ventilator weaning protocol — called a “wake up and breathe” strategy — helps patients come off the ventilator faster so that they can be discharged from the ICU and hospital more quickly.

The study was presented at the American Thoracic Society 2007 International Conference in San Francisco.

May 21 — OrbusNeich announced today it has received CE Mark approval for three interventional cardiology products: the Blazer cobalt chromium stent, the Sapphire PTCA dilatation catheter and the Lumina 6F guiding catheter.

Featuring unique dual helix design and thin cobalt chromium stent struts, Blazer enables physicians to overcome the flexibility challenges associated with the slotted tube construction of most stents. In addition, Blazer provides unsurpassed sidebranchability of up to 4.5 mm for effective bifurcation stenting and for maintaining the patency of side branches.

May 21, 2007 - VirtualScopics, Inc., a developer of image-based biomarker solutions, announced today that it released its next generation 2.0 software platform for the use of imaging in clinical trials, delivering operational efficiencies and enhanced reporting in order to expedite customers' clinical trial process.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now